Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group - sprookjes - yvandenbroek - TriplyDB

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

http://www.wikidata.org/entity/Q28241816

about

Viral hepatitis and hepatocellular carcinoma Lectin of Concanavalin A as an anti-hepatoma therapeutic agent Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection Glycyrrhizin versus antiviral drugs for chronic hepatitis B virus infection Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection Phyllanthus species for chronic hepatitis B virus infection Glycyrrhizin for chronic hepatitis B virus infection Phyllanthus species for chronic hepatitis B virus infection The history of tumor virology Emerging infectious determinants of chronic diseases The causal relation between human papillomavirus and cervical cancer.Developmental context determines latency of MYC-induced tumorigenesis Epidemiology and Prevention of Hepatitis B Virus Infection Modelling vaccination schedules for a cancer immunoprevention vaccine.Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials Historical review of the causes of cancer Early Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline?Risk Factors for the Development of Hepatocellular Carcinoma in Thailand Early-life exposures to infectious agents and later cancer development Molecular cancer prevention: Current status and future directions Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiation Applying what we know to accelerate cancer prevention Targeted therapy for hepatocellular carcinoma: novel agents on the horizon The impact of new vaccine introduction on immunization and health systems: a review of the published literature Emerging hepatitis B virus infection in vaccinated populations: a rising concern?Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?Viral hepatitis B and C in children Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience Prevention of Hepatocellular Carcinoma Vaccines versus immunotherapy: overview of approaches in deciding between options Chemoprevention in gastrointestinal cancers: current status Hepatitis B and the need for a booster dose Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Nuclear export and import of human hepatitis B virus capsid protein and particles Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer Virus-induced hepatocellular carcinoma with special emphasis on HBV.

P2860

Q21245597-14F73923-8822-4EB8-BA77-CF181524BB18 Q21284430-FF837974-E2CF-43BB-B28E-C0A2093A2924 Q24197858-9B41E974-9184-4FF9-8178-364ACF54F9DE Q24234383-FAF01F85-822D-441B-8A44-8C7E880BFEE0 Q24234607-4417B586-7E9B-48CB-B29F-2F600BC6B82E Q24235128-E6EFAC26-6FCE-44BD-9C58-AAFDCC8EC67D Q24235137-D612D35D-467E-410D-B546-58C681F9C31A Q24235338-83916450-A3F8-4777-B702-67D55988917F Q24610004-5351A408-49FB-4884-BFFF-A30179730B70 Q24628832-392F7C89-AE33-4388-A5AD-FDDE8AF4789B Q24673148-CF13024B-5830-4145-9C40-2680A4A9B3F5 Q24794847-A688953C-A4A5-4573-AD1E-A395813B893C Q24810152-F2177808-FF8C-4282-86EA-58EABF952DB4 Q24810987-E2C2FBCD-E063-4DD9-87A6-DC9C95C48AFF Q26750444-31759A5E-D622-4BE9-AE81-7078D9A1FECB Q26765196-30D9ED27-0E0A-40B3-A9BF-EE3B1678E978 Q26767036-14048604-A9E3-4989-AA76-40522C02D623 Q26768466-5A821718-4DB4-4371-B9D0-3AA252B2DB34 Q26775650-F2FF8FC7-E7A5-47C1-9D4A-23E89571274E Q26786103-F937C306-A4C0-43E7-9C08-2938E7C59230 Q26797207-AF912110-0660-47DE-9E76-815E22A03AE5 Q26849459-7C73830D-1312-4CB9-8646-A0DBBE3F8753 Q26851211-ED72894D-1777-43CD-B465-000D29BDFDCC Q26853527-1CDAEB35-6CDB-430C-80D5-1673570AC131 Q26864696-5C7033B5-E9EC-44AE-92E7-D7A12BD87C37 Q27002288-30540A1E-A013-454B-A542-DA8EB1AAF64C Q27009450-15FC4FD5-92A2-418A-875C-A53EA83E8A9C Q27012663-68689B74-12BE-4152-BEF0-6CE670773512 Q27025083-B48FB1E9-77A3-4C55-BF55-9E37E4474762 Q27473273-B58A6066-B975-49B0-A906-40940B9F7F20 Q27489394-294D1888-C16A-4C48-AC0A-9318B0F32CC3 Q27490250-2A8E6302-8CC1-4D44-A8FA-6D0E1C3479EB Q28079576-E243E557-3830-4623-B33D-9FEFF1F5E7B1 Q28085434-AC4FD922-21E0-4EDD-A64F-7F14019A6D90 Q28196514-4FAD384C-AD7A-4943-8067-70FFA64BBBCC Q28239937-54192A1C-222C-4922-84AF-7D70211C49E7 Q28272678-DA101D98-EBC1-43F8-849F-184ACF2980C3 Q28475960-AEBABD65-1052-48A0-9C4A-638D4CFD8937 Q28477819-7F7E3246-ACBE-4B66-896D-EEABD05DF23D Q30238961-37D8DF74-C154-4113-9654-477683E5A47C

P2860

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

http://www.wikidata.org/entity/Q28241816

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@ast

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@en

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@nl

type

label

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@ast

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@en

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@nl

prefLabel

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@ast

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@en

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@nl

P1433

Q28241816-C0F97CDE-AD53-435D-9B00-D7CA2BC41856

P1476

Q28241816-9CA5E019-6EB0-4214-A572-6050B6698F58

P2093

Q28241816-17BAA494-71DC-4B8A-8B57-2FF76DF85C3E

Q28241816-370223F5-211A-4B2D-96F2-0B9217D6621E

Q28241816-70442EF3-8657-4D9F-888C-E9BE681F7947

Q28241816-B37EFAC0-2ED7-4112-A7F6-4D82A4574D61

Q28241816-B9FA5393-1B40-4620-A78D-E2DD36DD5F53

Q28241816-D3BDF3EE-63A4-47ED-8EE2-A2DFD6054921

Q28241816-E51C3A8C-F860-4C1A-A675-9235A56C972A

P304

Q28241816-C8BCCBCE-ED72-4E28-A29A-05B14C089B3B

P31

Q28241816-3B15FCB6-D3EB-4BC7-9892-7F5B457FEADA

P3181

Q28241816-5F31754F-DB42-423D-8D85-C63168E1225C

P356

Q28241816-A9FF6937-9E65-43C2-947D-7B03D398EB77

P407

Q28241816-E5CB27F7-612B-414C-BB0B-31577C55809F

P433

Q28241816-DAD35E55-6A8A-427B-AB6B-DB149EFF31D3

P478

Q28241816-62D75BEF-F0B4-4D3D-9144-5284DBC17287

P50

Q28241816-0884EDEB-7850-4E99-B225-C2F83BB4FC1F

Q28241816-8C835E02-67F6-4BB1-8F31-136280892E2E

P577

Q28241816-1C50BEB0-A31F-4327-B936-0F18C9252E56

P698

Q28241816-1C0ABCCE-E155-4F6C-9687-D8B4FA6113EE

P3181

P356

NEJM199706263362602

P1433

The New England Journal of Medicine

P1476

Universal hepatitis B vaccinat ...... Childhood Hepatoma Study Group

@en

P2093

Chen CJ

http://www.w3.org/2001/XMLSchema#string

Chen DS

http://www.w3.org/2001/XMLSchema#string

Hsu HM

http://www.w3.org/2001/XMLSchema#string

Kong MS

http://www.w3.org/2001/XMLSchema#string

Liang DC

http://www.w3.org/2001/XMLSchema#string

Shau WY

http://www.w3.org/2001/XMLSchema#string

Wu TC

http://www.w3.org/2001/XMLSchema#string

P304

1855-1859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1379944

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM199706263362602

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

336

http://www.w3.org/2001/XMLSchema#string

P50

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9197213

http://www.w3.org/2001/XMLSchema#string